Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 2/20 | 0.39 |
| ▸ | CTSK | P43235 | 2/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | BID | P55957 | 3/20 | 0.30 |
| ▸ | BCL2L1 | Q07817 | 3/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.30 |
| ▸ | BAK1 | Q16611 | 3/20 | 0.30 |
| ▸ | MMP2 | P08253 | 2/20 | 0.30 |
| ▸ | F7 | P08709 | 2/20 | 0.30 |
| ▸ | F3 | P13726 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | ECE1 | P42892 | 1/20 | 0.30 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 0.30 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.30 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17016760 | 0.92 | CTSS (0.41) | CTSSCTSKCTSL | |
| SCHEMBL17016811 | 0.87 | CTSS (0.41) | CTSSCTSKCTSL | |
| SCHEMBL17016796 | 0.83 | RARB (0.36) | MAPT | |
| SCHEMBL17016807 | 0.82 | CTSS (0.42) | CTSSCTSKCTSL | |
| SCHEMBL17021060 | 0.82 | CTSS (0.42) | CTSSCTSKCTSL | |
| SCHEMBL14356142 | 0.80 | CTSS (0.47) | CTSSCTSKCTSLMAPTALOX15 | |
| SCHEMBL17016812 | 0.77 | CTSS (0.39) | CTSSCTSKCTSL | |
| SCHEMBL10302840 | 0.76 | CTSL (0.40) | CTSSCTSKCTSLMAPTALOX15 | |
| SCHEMBL18136390 | 0.76 | ALOX5 (0.45) | CTSSCTSKCTSLMAPTALOX15 | |
| SCHEMBL12579513 | 0.76 | CTSS (0.56) | CTSSCTSKCTSLKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9404040-B2 | Liquid crystal compound having fluorine-containing alkenyl terminal group, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2016-08-02 | — | — | US | disclosed |
| US-20150232759-A1 | Liquid crystal compound having fluorine-containing alkenyl terminal group, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2015-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150232759-A1 | Liquid crystal compound having fluorine-containing alkenyl terminal group, liquid crystal composition and liquid crystal display device | PYM1, CXCR1, LEO1 | CTSS 3411/4885CTSK 2711/4885CTSL 3148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.